International Scholarly Research Notices / 2014 / Article / Tab 2

Clinical Study

Evaluation of CD25+CD4+ Regulatory T-Lymphocyte Subpopulations in Coronary Artery Diseases Patients

Table 2

T-lymphocyte subpopulations in patients with stable and unstable coronary diseases.

Group 1Group 2   value

Leukocytes
(G/L)
7,12 ± 1,76,8 ± 2,7NS
Lymphocytes
(G/L)
2,76 ± 0,292,63 ± 0,48NS
T-lymphocytes (G/L)1,68 ± 0,421,69 ± 0,38NS
B-lymphocytes (G/L)0,26 ± 0,060,33 ± 0,08NS
Natural killers
(G/L)
0,36 ± 0,10,32 ± 0,09NS
T-helperlymphocytes
(G/L)
1,16 ± 0,41,00 ± 03NS
T-suppressor lymphocytes
(G/L)
0,7 ± 0,060,8 ± 0,07NS
Activated
T-lymphocytes
(G/L)
0,23 ± 0,080,28 ± 0,02<0,05